The statement that best describes cancer cells is that they are cells that grow and divide uncontrollably, ignore the body’s normal signals to stop dividing or die, and can invade surrounding tissues. While normal cells follow a tightly regulated cycle of growth, division, and death, cancer cells bypass every one of these controls. That single distinction, unregulated growth, underlies nearly everything else that makes cancer dangerous.
But that one-sentence answer only scratches the surface. Cancer cells differ from healthy cells in at least half a dozen measurable ways, from how they fuel themselves to how they look under a microscope. Understanding these traits explains why cancer behaves the way it does and why it can be so difficult to treat.
They Ignore Stop Signals and Keep Dividing
Normal cells divide only when they receive specific growth signals from the body, and they stop when suppressor signals tell them to. Cancer cells short-circuit both sides of this system. They either overproduce growth-promoting signals or lose the suppressor proteins that act as brakes. The result is a cell that divides over and over without permission.
One of the most important brakes is a protein called p53, produced by the TP53 gene. In a healthy cell, p53 detects DNA damage and either pauses division so the damage can be repaired or triggers the cell to self-destruct. Mutations in TP53 appear in almost every type of cancer, at rates ranging from about 5% in cancers like leukemia and melanoma to 38%–50% in ovarian, colorectal, lung, and esophageal cancers. When p53 stops working, damaged cells keep copying themselves, and every daughter cell inherits the same broken DNA.
They Refuse to Die
Healthy cells have a built-in self-destruct program called apoptosis. When a cell is too damaged or too old, this program activates, and the cell dies in an orderly way. Cancer cells override this process by cranking up the production of survival proteins that block the self-destruct signal. One of the best-known examples is BCL-2, first discovered in a type of lymphoma. Elevated levels of similar survival proteins have been found across breast, lung, and bone cancers, among others.
By dodging apoptosis, cancer cells accumulate. They also accumulate more mutations over time, because damaged cells that should have been destroyed instead survive and keep dividing.
They Can Divide Indefinitely
Normal cells have a built-in countdown clock. Every time a cell divides, the protective caps on the ends of its chromosomes, called telomeres, get a little shorter. After a set number of divisions, telomeres become too short to protect the DNA, and the cell stops dividing or dies. Cancer cells get around this limit by reactivating an enzyme called telomerase, which rebuilds telomere length after each division. Roughly 85% to 90% of all malignant tumors show telomerase activity, compared to little or none in most normal tissues. This effectively makes cancer cells immortal in terms of replication.
They Rewire Their Metabolism
Cancer cells consume glucose at dramatically higher rates than normal cells. In the 1920s, researcher Otto Warburg observed that tumors were absorbing enormous amounts of glucose compared to surrounding tissue and converting it to lactate, even when plenty of oxygen was available. Normal cells use oxygen to extract energy from glucose efficiently. Cancer cells rely heavily on a faster but less efficient process, fermentation, that produces lactate as a byproduct. This trait, known as the Warburg effect, is so consistent across cancers that modern imaging scans detect tumors by looking for areas of unusually high glucose uptake.
They Build Their Own Blood Supply
A tumor can only grow to about the size of a pinhead before it outstrips the oxygen and nutrients available from nearby blood vessels. To grow beyond that, cancer cells release signaling molecules that recruit new blood vessels to the tumor, a process called angiogenesis. The most common of these signals is vascular endothelial growth factor (VEGF), which is highly expressed across many tumor types. The blood vessels that tumors generate tend to be poorly organized and leaky, which, ironically, also makes it easier for cancer cells to slip into the bloodstream.
They Spread to Other Parts of the Body
The ability to invade surrounding tissue and spread to distant organs, called metastasis, is the trait that makes cancer life-threatening. This is a multi-step process. First, cancer cells break through the boundary layer that normally keeps them in place by releasing enzymes that dissolve the surrounding structural matrix. Some cancer cells move collectively in groups, with leading cells carving a path that followers widen. Others squeeze through tiny gaps individually, changing shape like amoebas.
Once free from the original tumor, cancer cells enter blood or lymph vessels. Lymph vessels are particularly easy to penetrate because they have thin walls with loose connections between cells and no surrounding muscle layer. Cancer cells that survive the journey through the circulatory system can exit at a distant site, take root, and form a new tumor. Not every cancer cell that enters the bloodstream succeeds at this. The process is inefficient, but it only takes a small number of cells colonizing a new organ to create a serious problem.
They Hide From the Immune System
Your immune system routinely identifies and destroys abnormal cells. Cancer cells survive by learning to camouflage themselves. One of the most well-understood tricks involves a protein called PD-L1 on the cancer cell’s surface. When PD-L1 binds to a receptor called PD-1 on an immune T cell, it sends an “off” signal that prevents the T cell from attacking. Tumors also exploit other inhibitory checkpoints like CTLA-4 to further suppress immune activity. This discovery led directly to a class of cancer treatments called checkpoint inhibitors, which block these deactivation signals and help the immune system recognize the tumor again.
They Look Different Under a Microscope
Cancer cells are visually distinct from normal cells. One of the clearest differences is the nucleus-to-cytoplasm ratio: the nucleus (the part that holds DNA) takes up a larger proportion of the cell. In lab measurements, malignant cell lines show a nucleus-to-cytoplasm ratio of about 0.6 to 0.73, while a non-malignant cell line measured around 0.53. That may sound like a small difference, but under a microscope it’s noticeable, and pathologists use this ratio as one indicator when evaluating tissue samples. Cancer cell nuclei also tend to be irregular in shape and vary more in size compared to the uniform appearance of healthy cells.
Genetic Instability Ties It All Together
Underlying every trait listed above is a fundamental feature: cancer cells have unstable genomes. Their DNA repair systems are often broken, which means mutations accumulate faster with each round of division. This genetic instability is what allows cancer cells to “acquire” the other traits over time. A single mutation rarely causes cancer on its own. Instead, cells accumulate damage across multiple regulatory genes over months or years, gradually gaining the ability to dodge one safeguard after another. This is why cancer risk increases with age and why cancer is best understood not as a single event but as a process of progressive cellular breakdown.